Quantitative MRI measures of cartilage predict knee replacement: A case-control study from the Osteoarthritis Initiative

Annals of the Rheumatic Diseases

Volumn 72, Issue 5, 2013, Pages 707-714

  Eckstein, Felix ^a,b   Kwoh, C Kent ^c   Boudreau, Robert M ^d   Wang, Zhijie ^c   Hannon, Michael J ^c   Cotofana, Sebastian ^a,b   Hudelmaier, Martin I ^a,b   Wirth, Wolfgang ^a,b   Guermazi, Ali ^e   Nevitt, Michael C ^f   John, Markus R ^g   Hunter, David J ^h  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

^b Chondrometrics GmbH   (Germany)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g NOVARTIS PHARMA AG   (Switzerland)

^h UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; AREA UNDER THE CURVE; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; FEMUR; FOLLOW UP; GENDER; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE PROCESSING; KNEE ARTHROPLASTY; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL SYSTEM PARAMETERS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; TIBIA;

AGED; ARTHROPLASTY, REPLACEMENT, KNEE; CARTILAGE, ARTICULAR; CASE-CONTROL STUDIES; CLINICAL TRIALS AS TOPIC; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; ROC CURVE;

EID: 84875930050     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-201164     Document Type: Article

References (57)

1. Lawrence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008;1:26-35.
2. Kotlarz H, Gunnarsson CL, Fang H, et al. Insurer and out-of-pocket costs of osteoarthritis in the US: evidence from national survey data. Arthritis Rheum 2009; 12:3546-53.
3. Guccione AA, Felson DT, Anderson JJ, et al. The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health 1994;3:351-8. (Pubitemid 24107816)
4. Losina E, Walensky RP, Reichmann WM, et al. Impact of obesity and knee osteoarthritis on morbidity and mortality in older Americans. Ann Intern Med 2011;4:217-26.
5. Wright EA, Katz JN, Cisternas MG, et al. Impact of knee osteoarthritis on health care resource utilization in a US population-based national sample. Med Care 2010;9:785-91.
6. Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008;2:137-62. (Pubitemid 351222155)
7. Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet 2011;9783:2115-26.
8. Kurtz S, Ong K, Lau E, et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007;4:780-5. (Pubitemid 46564282)
9. Guidance for industry on clinical development programs for drugs, devices and biological products intended for the treatment of osteoarthritis (OA). www fda gov/ GuidanceComlianceRegulatoryInformation/GUidances/ucm071577 pdf 1999. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Devices and Radiological Health (CDRH). Accessed 8th June 2012.
10. Eckstein F, Cicuttini F, Raynauld JP, et al. Magnetic resonance imaging (MRI) of articular cartilage in knee osteoarthritis (OA): morphological assessment. Osteoarthritis Cartilage 2006;14(Suppl A):A46-75.
11. Eckstein F, Burstein D, Link TM. Quantitative MRI of cartilage and bone: degenerative changes in osteoarthritis. NMR Biomed 2006;7:822-54. (Pubitemid 44811544)
12. Eckstein F, Guermazi A, Roemer FW. Quantitative MR imaging of cartilage and trabecular bone in osteoarthritis. Radiol Clin North Am 2009;4:655-73.
13. Graichen H, Eisenhart-Rothe R, Vogl T, et al. Quantitative assessment of cartilage status in osteoarthritis by quantitative magnetic resonance imaging: technical validation for use in analysis of cartilage volume and further morphologic parameters. Arthritis Rheum 2004;3:811-16. (Pubitemid 38326181)
14. Hunter DJ, Zhang W, Conaghan PG, et al. Systematic review of the concurrent and predictive validity of MRI biomarkers in OA. Osteoarthritis Cartilage 2011;5:557-88.
15. Conaghan PG, Hunter DJ, Maillefert JF, et al. Summary and recommendations of the OARSI FDA osteoarthritis Assessment of Structural Change Working Group. Osteoarthritis Cartilage 2011;5:606-10.
16. Bruyere O, Richy F, Reginster JY. Three year joint space narrowing predicts long term incidence of knee surgery in patients with osteoarthritis: an eight year prospective follow up study. Ann Rheum Dis 2005;12:1727-30. (Pubitemid 41667146)
17. Bruyere O, Pavelka K, Rovati LC, et al. Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials. Osteoarthritis Cartilage 2008;2:254-60. (Pubitemid 351218188)
18. Dougados M, Hawker G, Lohmander S, et al. OARSI/OMERACT criteria of being considered a candidate for total joint replacement in knee/hip osteoarthritis as an endpoint in clinical trials evaluating potential disease modifying osteoarthritic drugs. J Rheumatol 2009;9:2097-9.
19. Gossec L, Paternotte S, Maillefert JF, et al. The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on Total Joint Replacement. Osteoarthritis Cartilage 2011;2:147-54.
20. Bauer DC, Hunter DJ, Abramson SB, et al. Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthritis Cartilage 2006;8:723-7. (Pubitemid 43986366)
21. Peterfy CG, Schneider E, Nevitt M. The osteoarthritis initiative: report on the design rationale for the magnetic resonance imaging protocol for the knee. Osteoarthritis Cartilage 2008;12:1433-41.
22. Nevitt MC, Peterfy C, Guermazi A, et al. Longitudinal performance evaluation and validation of fixed-flexion radiography of the knee for detection of joint space loss. Arthritis Rheum 2007;5:1512-20. (Pubitemid 46764080)
23. Peterfy C, Li J, Zaim S, et al. Comparison of fixed-flexion positioning with fluoroscopic semi-flexed positioning for quantifying radiographic joint-space width in the knee: test-retest reproducibility. Skeletal Radiol 2003;3:128-32. (Pubitemid 36818111)
24. Eckstein F, Hudelmaier M, Wirth W, et al. Double echo steady state magnetic resonance imaging of knee articular cartilage at 3 Tesla: a pilot study for the Osteoarthritis Initiative. Ann Rheum Dis 2006;4:433-41.
25. Wirth W, Nevitt M, Hellio Le Graverand MP, et al. Sensitivity to change of cartilage morphometry using coronal FLASH, sagittal DESS, and coronal MPR DESS protocols - comparative data from the Osteoarthritis Initiative (OAI). Osteoarthritis Cartilage 2010;4:547-54.
26. Eckstein F, Benichou O, Wirth W, et al. Direct comparison of cartilage loss in painful contra-lateral knees with and without joint space narrowing - data from the Osteoarthritis Initiative (OAI). Arthritis Care Res 2009;9:1218-25.
27. Wirth W, Eckstein F. A technique for regional analysis of femorotibial cartilage thickness based on quantitative magnetic resonance imaging. IEEE Trans Med Imaging 2008;6:737-44. (Pubitemid 351760846)
28. Eckstein F, Ateshian G, Burgkart R, et al. Proposal for a nomenclature for magnetic resonance imaging based measures of articular cartilage in osteoarthritis. Osteoarthritis Cartilage 2006;10:974-83. (Pubitemid 44309414)
29. Buck RJ, Wyman BT, Le Graverand MP, et al. An efficient subset of morphological measures for articular cartilage in the healthy and diseased human knee. Magn Reson Med 2010;3:680-90.
30. Eckstein F, Buck RJ, Burstein D, et al. Precision of 3.0 Tesla quantitative magnetic resonance imaging of cartilage morphology in a multicentre clinical trial. Ann Rheum Dis 2008;12:1683-8.
31. Wirth W, Hellio Le Graverand MP, Wyman BT, et al. Regional analysis of femorotibial cartilage loss in a subsample from the Osteoarthritis Initiative progression subcohort. Osteoarthritis Cartilage 2009;3:291-7.
32. Hudelmaier M, Wirth W, Wehr B, et al. Femorotibial cartilage morphology: reproducibility of different metrics and femoral regions, and sensitivity to change in disease. Cells Tissues Organs 2010;5:340-50.
33. Le Graverand MP, Buck RJ, Wyman BT, et al. Change in regional cartilage morphology and joint space width in osteoarthritis participants versus healthy controls: a multicentre study using 3.0 Tesla MRI and Lyon-Schuss radiography. Ann Rheum Dis 2010;1:155-62.
34. Eckstein F, Nevitt M, Gimona A, et al. Rates of change and sensitivity to change in cartilage morphology in healthy knees and in knees with mild, moderate, and end stage radiographic osteoarthritis. Arthritis Care Res (Hoboken) 2011;63(3): 311-9.
35. Saunders J, Ding C, Cicuttini F, et al. Radiographic osteoarthritis and pain are independent predictors of knee cartilage loss: a prospective study. Intern Med J 2012;42(3):274-80.
36. Eckstein F, Cotofana S, Wirth W, et al. Greater rates of cartilage loss in painful knees than in pain-free knees after adjustment for radiographic disease stage: data from the osteoarthritis initiative. Arthritis Rheum 2011;8:2257-67.
37. Janes H, Pepe MS. Matching in studies of classification accuracy: implications for analysis, efficiency, and assessment of incremental value. Biometrics 2008;1:1-9. (Pubitemid 351316856)
38. Cicuttini FM, Jones G, Forbes A, et al. Rate of cartilage loss at two years predicts subsequent total knee arthroplasty: a prospective study. Ann Rheum Dis 2004;9:1124-7. (Pubitemid 39120365)
39. Tanamas SK, Wluka AE, Pelletier JP, et al. The association between subchondral bone cysts and tibial cartilage volume and risk of joint replacement in people with knee osteoarthritis: a longitudinal study. Arthritis Res Ther 2010;2:R58.
40. Scher C, Craig J, Nelson F. Bone marrow edema in the knee in osteoarthrosis and association with total knee arthroplasty within a three-year follow-up. Skeletal Radiol 2008;7:609-17.
41. Dore D, Quinn S, Ding C, et al. Natural history and clinical significance of MRI-detected bone marrow lesions at the knee: a prospective study in community dwelling older adults. Arthritis Res Ther 2010;6:R223.
42. Tanamas SK, Wluka AE, Pelletier JP, et al. Bone marrow lesions in people with knee osteoarthritis predict progression of disease and joint replacement: a longitudinal study. Rheumatology (Oxford) 2010;12:2413-19.
43. Felson DT, Chaisson CE, Hill CL, et al. The association of bone marrow lesions with pain in knee osteoarthritis. Ann Intern Med 2001;7:541-9. (Pubitemid 32245315)
44. Felson DT, McLaughlin S, Goggins J, et al. Bone marrow edema and its relation to progression of knee osteoarthritis. Ann Intern Med 2003;5(Pt 1):330-6.
45. Hunter DJ, Zhang Y, Niu J, et al. Increase in bone marrow lesions associated with cartilage loss: a longitudinal magnetic resonance imaging study of knee osteoarthritis. Arthritis Rheum 2006;5:1529-35.
46. Raynauld JP, Martel-Pelletier J, Berthiaume MJ, et al. Correlation between bone lesion changes and cartilage volume loss in patients with osteoarthritis of the knee as assessed by quantitative magnetic resonance imaging over a 24-month period. Ann Rheum Dis 2008;5:683-8. (Pubitemid 351571934)
47. Roemer FW, Zhang Y, Niu J, et al. Tibiofemoral joint osteoarthritis: risk factors for MR-depicted fast cartilage loss over a 30-month period in the multicenter osteoarthritis study. Radiology 2009;3:772-80.
48. Raynauld JP, Martel-Pelletier J, Haraoui B, et al. Risk factors predictive of joint replacement in a 2-year multicentre clinical trial in knee osteoarthritis using MRI: results from over 6 years of observation. Ann Rheum Dis 2011;8:1382-8.
49. Mazzuca SA, Brandt KD, Katz BP, et al. Risk factors for progression of tibiofemoral osteoarthritis: an analysis based on fluoroscopically standardised knee radiography. Ann Rheum Dis 2006;4:515-19.
50. Benichou OD, Hunter DJ, Nelson DR, et al. One-year change in radiographic joint space width in patients with unilateral joint space narrowing: data from the Osteoarthritis Initiative. Arthritis Care Res (Hoboken) 2010;7:924-31.
51. Wirth W, Buck R, Nevitt M, et al. MRI-based extended ordered values more efficiently differentiate cartilage loss in knees with and without joint space narrowing than region-specific approaches using MRI or radiography - data from the OA initiative. Osteoarthritis Cartilage 2011;6:689-99.
52. Neogi T, Felson D, Niu J, et al. Association between radiographic features of knee osteoarthritis and pain: results from two cohort studies. BMJ 2009;b2844.
53. Zhao D, Banks SA, D'Lima DD, et al. In vivo medial and lateral tibial loads during dynamic and high flexion activities. J Orthop Res 2007;5:593-602. (Pubitemid 46730512)
54. Ledingham J, Regan M, Jones A, et al. Radiographic patterns and associations of osteoarthritis of the knee in patients referred to hospital. Ann Rheum Dis 1993;7:520-6. (Pubitemid 23227217)
55. Moisio K, Eckstein F, Chmiel JS, et al. Denuded subchondral bone and knee pain in persons with knee osteoarthritis. Arthritis Rheum 2009;12:3703-10.
56. Ding C, Cicuttini F, Jones G. Tibial subchondral bone size and knee cartilage defects: relevance to knee osteoarthritis. Osteoarthritis Cartilage 2007;5:479-86. (Pubitemid 46667721)
57. Eckstein F, Hudelmaier M, Cahue S, et al. Medial-to-lateral ratio of tibiofemoral subchondral bone area is adapted to alignment and mechanical load. Calcif Tissue Int 2009;3:186-94.